Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases — Stella

Home/Lung Injury/

View on ClinicalTrials.gov

Recruiting

Back to Lung Injury trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Beijing 302 Hospital, Beijing

Key details

Phase

Early testing / Safety & dosing

Sponsor

Cell Energy Life Sciences Group Co. LTD

Collaborators

Beijing 302 Hospital

Enrollment target

~80 participants

Started

May 2023

Primary completion

May 2026

Age range

18 Years – 90 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.